Vaccinated people generated an overall protective immune response to the Delta and Omicron strains of COVID-19, though with slightly fewer antibodies for the mutated parts of the virus.

A research team helmed by Sarver Heart Center Associate Director Hossein Ardehali, MD, PhD, illuminates a potential path toward reversing a type of heart disease that lacks good treatments.

The Madhavan Lab offers students and postdocs valuable opportunities to engage the public and sharpen their communication skills.

Innovations from the U of A College of Medicine – Tucson, the Asthma and Airway Disease Research Center and the BIO5 Institute are targeting the deeper causes of asthma and COPD.

An FDA-approved osteoporosis treatment might nudge a mutated protein back into shape and improve heart function, according to a study by University of Arizona College of Medicine – Tucson researchers.

With antibiotic resistance on the rise, Michael D. L. Johnson, PhD, is on a mission to discover new ways to neutralize harmful microorganisms.

An international research team co-led by Sarver Heart Center Director Hesham Sadek, MD, PhD, shows that about 25% of patients with artificial hearts can regenerate heart muscle after a heart attack.

Parkinson’s disease causes difficulty in movement and balance, but its cognitive symptoms receive less attention and have no good treatments. A College of Medicine – Tucson team hopes to change that.

Rob Jackson, PhD, a postdoctoral researcher in the Department of Immunobiology, secured a pivotal National Institutes of Health grant to establish his career in virology and oral cancer.

Researchers in the Department of Psychiatry will use a $3M grant from the Department of Defense to examine a noninvasive, drug-free treatment for sleep disorders.